Biotech Inscript

About Publications Sign in Subscribe

Biocon Appoints Peter Bains as Group CEO to Drive Growth and Synergy

Biocon Ltd appoints Mr. Peter Bains as Group CEO, focusing on growth and synergy. He brings global biopharmaceutical expertise and a history with the Biocon Group, overseeing strategic leadership among its core businesses.

Axolotl Biologix and Carmell Therapeutics Merge to Pioneer Regenerative Medicine Advancements

Axolotl Biologix and Carmell Therapeutics Merge to Pioneer Regenerative Medicine Advancements

Flagstaff's Axolotl Biologix merges with Carmell Therapeutics, a major move in regenerative medicine. $65 million initial value with potential for $75 million more in milestone payments. Pioneering innovations expected in soft tissue repair and orthopedics.

Former Google AI Expert's Biotech Start-Up Raises $100 Million for AI-Driven Drug Innovation

Former Google AI Expert's Biotech Start-Up Raises $100 Million for AI-Driven Drug Innovation

Inceptive, founded by a former Google AI expert, secures $100M in funding from investors like Nvidia and Andreessen Horowitz to advance AI-driven biotech initiatives

University of Birmingham and Acticor Biotech Gain Regulatory Approval for Groundbreaking LIBERATE Clinical Study

University of Birmingham and Acticor Biotech Gain Regulatory Approval for Groundbreaking LIBERATE Clinical Study

Birmingham - September 9, 2023: In a momentous development for cardiovascular medicine, the University of Birmingham and Acticor Biotech have received full regulatory approval for the LIBERATE clinical study. This study marks a significant stride towards potential breakthroughs in the treatment of heart attacks, using the novel antithrombotic drug, glenzocimab.

Embracing Biopharming at the London Biotechnology Show: A Revolutionary Path to Sustainable Medicine

Nature has been a perennial source of remedy and cure for humanity. We have Aspirin yielding willow trees, and Artemisinin used as treatment for malaria. Adding to these magical powers of nature, science has manipulated it more to produce high-valued pharmaceuticals. This method to transform plants, animals and microbes into

Scientists Unveil Promising Bacterial Blueprint to Combat Antibiotic Resistance

01 July, 2023: A global team of scientists, including researchers from Trinity College Dublin, has achieved detailed knowledge about the structure of a crucial bacterial enzyme. This breakthrough could assist chemists in developing novel medications to inhibit the enzyme and effectively combat disease-causing bacteria. The significance of their research cannot

NHS Introduces Life-Saving Drug For Premature Babies' Vision

4 July 2023: Premature infants in England can now receive drug treatment as a routine measure on the National Health Service (NHS), aimed at preventing blindness. This marks the first instance where such treatment is made available for premature babies within the NHS in England. Normally, infants who have Retinopathy